| Eric I Muca, DPM | |
|
333 Lincoln St, Saco, ME 04072-3113 | |
| (207) 282-6330 | |
| (207) 283-3338 |
| Full Name | Eric I Muca |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 28 Years |
| Location | 333 Lincoln St, Saco, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558330217 | NPI | - | NPPES |
| 038319 | Other | ANTHEM | |
| 2292732 | Other | AETNA | |
| 6793980001 | Other | ME | MEDICARE PTAN |
| 6793980001 | Other | NCS DME | |
| 038319 | Other | ME | ANTHEM |
| 221470099 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | POD1025 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Provider Name | Eric Muca Dpm Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649616327 PECOS PAC ID: 3072752575 Enrollment ID: O20130613000116 |
News Archive
A treatment strategy designed to minimise the effects of accelerated repopulation using hypofractionated radiotherapy with chemotherapy is feasible for patients with stage III non-small-cell lung cancer, according to UK researchers.
A recent case report published on May 14, 2010 in World Journal of Gastroenterology describes the imaging features of a ruptured superior mesenteric artery aneurysm,which created a giant hematoma and mimicked a pancreatic mass, with mild dilatation of main pancreatic duct.
As Idaho families, businesses and retirees struggle with soaring health care costs, a vague bill aimed at tackling an issue in a non-existent federal health care law could make the crisis worse for many of the state's residents. The Idaho Health Freedom Act (HB 391) is set to be heard by Idaho Senate State Affairs Committee tomorrow morning, and AARP says the legislation is unproven, untried and vague and is urging them to reject the bill.
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
While record numbers of hospitals and doctors participate in electronic health information exchange efforts, which enable medical histories to follow patients as they move between healthcare providers, the long-term success of these programs is in question.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric I Muca, DPM 333 Lincoln St, Saco, ME 04072-3113 Ph: (207) 282-6330 | Eric I Muca, DPM 333 Lincoln St, Saco, ME 04072-3113 Ph: (207) 282-6330 |
News Archive
A treatment strategy designed to minimise the effects of accelerated repopulation using hypofractionated radiotherapy with chemotherapy is feasible for patients with stage III non-small-cell lung cancer, according to UK researchers.
A recent case report published on May 14, 2010 in World Journal of Gastroenterology describes the imaging features of a ruptured superior mesenteric artery aneurysm,which created a giant hematoma and mimicked a pancreatic mass, with mild dilatation of main pancreatic duct.
As Idaho families, businesses and retirees struggle with soaring health care costs, a vague bill aimed at tackling an issue in a non-existent federal health care law could make the crisis worse for many of the state's residents. The Idaho Health Freedom Act (HB 391) is set to be heard by Idaho Senate State Affairs Committee tomorrow morning, and AARP says the legislation is unproven, untried and vague and is urging them to reject the bill.
Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
While record numbers of hospitals and doctors participate in electronic health information exchange efforts, which enable medical histories to follow patients as they move between healthcare providers, the long-term success of these programs is in question.
› Verified 3 days ago
Dr. Harold E Chamberlin, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 333 Lincoln Street, Kimball Health Ctr, Saco, ME 04072 Phone: 207-282-6330 Fax: 207-283-3338 | |
Eric Muca Dpm Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 333 Lincoln St, Saco, ME 04072 Phone: 207-282-6330 Fax: 207-283-3338 |